Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-18

Clinical Trial Update: The Effect of Linagliptin on Mitochondrial and Endothelial Function [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating linagliptin's effects on mitochondrial and endothelial function in Type 2 diabetes mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tradjenta (Linagliptin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Type II Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-11-18